Feasibility Study Using the Xoft Axxent Electronic Brachytherapy System for the Treatment of Endometrial Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Endometrial Cancer
Female
Endometrial Cancer
Trial Information
Feasibility Study Using the Xoft Axxent Electronic Brachytherapy System for the Treatment of Endometrial Cancer
Inclusion Criteria:
- Most types of endometrial (uterine) cancer Stage I and Stage II (see exclusion
criteria below)
- Post hysterectomy
Exclusion Criteria:
- Endometrial (uterine) cancer Stage IA Grade 1
- Scleroderma
- Collagen vascular disease
- Active Lupus
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Assess Number of Patients Who Were Able to Complete Treatment Delivery Using the Axxent Electronic Brachytherapy System
Outcome Time Frame:
through completion of radiation therapy
Safety Issue:
No
Principal Investigator
Adam Dickler, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Little Company of Mary
Authority:
United States: Institutional Review Board
Study ID:
TPR-0209
NCT ID:
NCT01045187
Start Date:
October 2008
Completion Date:
April 2010
Related Keywords:
- Endometrial Cancer
- endometrial cancer
- Uterine cancer
- electronic brachytherapy
- Xoft
- Endometrial Neoplasms
- Sarcoma, Endometrial Stromal
- Adenoma
Name | Location |
|---|---|
| Rhode Island Hospital | Providence, Rhode Island 02903 |
| Swedish Covenant Hospital | Chicago, Illinois 60625 |
| Little Company of Mary Hospital | Evergreen Park, Illinois 60805 |
| Cancer Treatment Services Arizona | Casa Grande, Arizona 85222 |
| Southwest Oncology Center | Phoenix, Arizona 85251 |
| Beverly Oncology & Imaging Medical Center, Inc | Montebello, California 90640 |
